Mobileye N.V. (NYSE:MBLY) shares are trading +0.00% thus far today and have traded in the range of 63.26 – 63.28 during the current session. In order to take a look at where the stock might headed longer term, we can also look at different sets of data. Sell-side research firms currently have a consensus one year price target of $61.81 on the stock according to First Call. This number can often vary from the Zacks or FactSet mean targets. The sell-side analysts are projecting earnings per share of $0.27 for the next fiscal quarter. For the current year, analysts are predicting earnings of $1.05 per share according to First Call.
Stock Technicals in Focus
In looking at where the stock is trading on a technical level, the stock is trading +0.73% away from its 50 day moving average of $62.82. Based on the most recent available data, the equity is -0.16% off of its 52-week high of $63.38 and +87.83% away from its 52-week low which is $33.69. In taking a look at the company’s valuation, the firm’s price to earnings ratio stands at 124.08. This is a crucial indicator investors watch as higher ratios compared to peers, would suggest higher future earnings growth potential for the stock. The price to current year EPS estimates from research analysts currently stands at 60.27. In looking further ahead, potential investors should note that the company’s price to next year’s EPS estimates is 40.31.
Today, the stock opened at $63.27 and the last bid at the time of writing stood at $63.28. During the session thus far, the equity dipped down to $63.26 and touched $63.28 as the high point. Mobileye N.V. Ordinary Shares has a market cap of 14.04B and has seen an average daily volume of 2930090 over the past three months.
Pfizer, Inc. (NYSE:PFE) shares have a current ABR (average broker recommendation) of 2.29. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.
Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Pfizer, Inc. (NYSE:PFE). The highest current target is $52. The lowest price target out of the polled analysts is presently $33. The consensus target price is currently noted at $38.3. Analysts may employ various techniques to help predict future stock price levels.
On the earnings front, Pfizer, Inc. (NYSE:PFE) is expected to post quarterly earnings per share of $0.65. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-08-01. Pfizer, Inc. (NYSE:PFE) most recently reported quarterly EPS of $0.69 for the quarter ending 2017-03-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 2.99%.